Stryve Foods (SNAX) 10-Q 16 Aug 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2021	Aug. 09, 2021
Affiliate, Collateralized Security [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	001-38785
Entity Registrant Name	STRYVE FOODS, INC.
Entity Central Index Key	0001691936
Entity Tax Identification Number	87-1760117
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	5801 Tennyson Parkway
Entity Address, Address Line Two	Suite 275
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75024
City Area Code	(972)
Local Phone Number	987-5130
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,017,321
Class A Common Stock [Member]
Affiliate, Collateralized Security [Line Items]
Title of 12(b) Security	Class A Common Stock
Trading Symbol	SNAX
Security Exchange Name	NASDAQ
Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share [Member]
Affiliate, Collateralized Security [Line Items]
Title of 12(b) Security	Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	SNAXW
Security Exchange Name	NASDAQ

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current Assets
Cash	$ 59,163	$ 198,192
Prepaid expenses and other current assets	29,000
Total Current Assets	88,163	198,192
Marketable securities held in Trust Account	13,543,086	13,545,503
TOTAL ASSETS	13,631,249	13,743,695
Current liabilities
Accounts payable and accrued expenses	2,167,337	883,176
Total Current Liabilities	2,167,337	883,176
Warrant Liability	869,000
Total Liabilities	3,036,337	883,176
Commitments and Contingencies (Note 6)
Ordinary shares subject to possible redemption, 1,322,096 and 767,392 shares at redemption value at June 30, 2021 and December 31, 2020, respectively	13,543,086	7,860,513
Shareholders’ (Deficit) Equity
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 3,095,000 and 3,650,004 shares issued and outstanding (excluding 1,322,096 and 767,392 shares subject to possible redemption) at June 30, 2021 and December 31, 2020 respectively	310	365
Additional paid-in capital		3,849,880
(Accumulated Deficit) Retained earnings	(2,948,484)	1,149,761
Total Shareholders’ (Deficit) Equity	(2,948,174)	5,000,006
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY	$ 13,631,249	$ 13,743,695

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Ordinary shares subject to redemption	1,322,096	767,392
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	100,000,000	100,000,000
Ordinary shares, shares issued	3,095,000	3,650,004
Ordinary shares, shares outstanding	3,095,000	3,650,004

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Formation and operating costs	$ 691,715	$ 834,124	$ 1,394,191	$ 978,461
Loss from operations	(691,715)	(834,124)	(1,394,191)	(978,461)
Other income (expense):
Interest earned on marketable securities held in Trust Account	338	111,658	657	530,255
Unrealized (loss) gain on marketable securities held in Trust Account		(58,537)		382
Change in fair value of warrant liabilities	(98,750)		(869,000)
Other (expense) income, net	(98,412)	53,121	(868,343)	530,637
Net loss	$ (790,127)	$ (781,003)	$ (2,262,534)	$ (447,824)
Basic and diluted weighted average shares outstanding, Ordinary shares subject to possible redemption	1,322,096	10,332,435	1,046,175	10,338,488
Basic and diluted net loss per share, Ordinary shares subject to possible redemption	$ 0	$ 0	$ 0	$ 0.05
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares	3,095,000	3,562,575	3,370,969	3,556,513
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ (0.26)	$ (0.23)	$ (0.67)	$ (0.27)

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2019	$ 355	$ 3,266,203	$ 1,733,450	$ 5,000,008
Balance, shares at Dec. 31, 2019	3,550,450
Change in value of ordinary shares subject to possible redemption	$ 1	(333,180)		(333,179)
Change in value of ordinary shares subject to possible redemption, shares	12,125
Net income (loss)			333,179	333,179
Balance at Mar. 31, 2020	$ 356	2,993,023	2,066,629	5,000,008
Balance, shares at Mar. 31, 2020	3,562,575
Balance at Dec. 31, 2019	$ 355	3,266,203	1,733,450	5,000,008
Balance, shares at Dec. 31, 2019	3,550,450
Net income (loss)				(447,824)
Balance at Jun. 30, 2020	$ 363	3,714,019	1,285,626	5,000,008
Balance, shares at Jun. 30, 2020	3,634,473
Balance at Mar. 31, 2020	$ 356	2,993,023	2,066,629	5,000,008
Balance, shares at Mar. 31, 2020	3,562,575
Change in value of ordinary shares subject to possible redemption	$ 7	780,996		781,003
Change in value of ordinary shares subject to possible redemption, shares	71,898
Net income (loss)			(781,003)	(781,003)
Balance at Jun. 30, 2020	$ 363	3,714,019	1,285,626	5,000,008
Balance, shares at Jun. 30, 2020	3,634,473
Balance at Dec. 31, 2020	$ 365	3,849,880	1,149,761	5,000,006
Balance, shares at Dec. 31, 2020	3,650,004
Change in value of ordinary shares subject to possible redemption	$ (55)	(3,849,880)	(1,835,374)	(5,685,309)
Change in value of ordinary shares subject to possible redemption, shares	(555,004)
Net income (loss)			(1,472,407)	(1,472,407)
Balance at Mar. 31, 2021	$ 310		(2,158,020)	(2,157,710)
Balance, shares at Mar. 31, 2021	3,095,000
Balance at Dec. 31, 2020	$ 365	3,849,880	1,149,761	5,000,006
Balance, shares at Dec. 31, 2020	3,650,004
Net income (loss)				(2,262,534)
Balance at Jun. 30, 2021	$ 310		(2,948,484)	(2,948,174)
Balance, shares at Jun. 30, 2021	3,095,000
Balance at Mar. 31, 2021	$ 310		(2,158,020)	(2,157,710)
Balance, shares at Mar. 31, 2021	3,095,000
Change in value of ordinary shares subject to possible redemption			(337)	(337)
Change in value of ordinary shares subject to possible redemption, shares
Net income (loss)			(790,127)	(790,127)
Balance at Jun. 30, 2021	$ 310		$ (2,948,484)	$ (2,948,174)
Balance, shares at Jun. 30, 2021	3,095,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Cash Flows from Operating Activities:
Net (loss)	$ (790,127)	$ (781,003)	$ (2,262,534)	$ (447,824)
Adjustments to reconcile net (loss) to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account			(657)	(530,255)
Unrealized (gain) loss on marketable securities held in Trust Account		58,537		(382)
Change in fair value of warrant liability	98,750		869,000
Changes in operating assets and liabilities:
Prepaid expenses and other current assets			(29,000)	(27,258)
Accounts payable			1,284,162	721,419
Net cash used in operating activities			(139,029)	(284,300)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account for working capital purposes				100,000
Cash withdrawn from Trust Account for redemption of Ordinary Shares			3,073
Net cash provided by investing activities			3,073	100,000
Cash Flows from Financing Activities:
Redemption of ordinary shares			(3,073)
Net cash used in financing activities			(3,073)
Net Change in Cash			(139,029)	(184,300)
Cash – Beginning			198,192	352,524
Cash – Ending	$ 59,163	$ 168,224	59,163	168,224
Non-Cash Investing and Financing Activities:
Change in value of ordinary shares subject to possible redemption			$ 5,682,573	$ (447,824)

Organization and Plan of Busine

Organization and Plan of Business Operations	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Plan of Business Operations	Note 1 - Organization and Plan of Business Operations Stryve Foods, Inc. (f/k/a Andina Acquisition Corp. III) (the “Company”) was incorporated in the Cayman Islands on July 29, 2016 as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (an “Initial Business Combination”). The Company’s efforts to identify a prospective target business were not limited to a particular industry or geographic region, although the Company initially intended to focus on target businesses in the Americas. All activity through June 30, 2021 related to the Company’s formation, its initial public offering (the “Initial Public Offering”), which is described below, and since the closing of the Initial Public Offering, the Company’s search for an Initial Business Combination, specifically, activities in connection with the announced and subsequently terminated proposed acquisition of EMMAC Life Sciences Limited, (“EMMAC”) (which activities ceased in November 2020) and activities in connection with the Business Combination (as defined below) with Stryve Foods LLC (“Stryve”), as described below. On July 20, 2021 (the “Closing Date”), the Company completed the previously announced business combination (the “Business Combination”) pursuant to that certain Business Combination Agreement (the “Business Combination Agreement”) by and among the Company, Andina Holdings LLC, a Delaware limited liability company (“Holdings”) and a wholly-owned subsidiary of the Company, B. Luke Weil, in the capacity from and after the closing of the transactions contemplated by the Business Combination Agreement as the representative for the shareholders of the Company (other than the Seller) (the “Purchaser Representative”), Stryve, Stryve Foods Holdings, LLC, a Texas limited liability company (the “Seller”), and R. Alex Hawkins, in the capacity from and after the Closing as the representative for the members of the Seller (the “Seller Representative”). As contemplated by the Business Combination Agreement, on or before the Closing Date, the following occurred: (i) the Seller and Stryve conducted a reorganization via a merger pursuant to which the Seller became a holding company for Stryve, the former owners of Stryve became the owners of the Seller, and the former holders of convertible notes of Stryve became holders of convertible notes of the Seller, and pursuant to which Stryve retained all of its subsidiaries, business, assets and liabilities, and became a wholly-owned subsidiary of the Seller, (ii) the Company was transferred by way of continuation out of the Cayman Islands and domesticated as a corporation in the State of Delaware, (iii) the Seller contributed to Holdings all of the issued and outstanding equity interests of Stryve in exchange for 11,502,355 37.9 7.8 10.4 0.0001 On July 20, 2021, in connection with the completion of the Business Combination and as contemplated by the Business Combination Agreement, the Company: (i) issued 4,250,000 42.5 1,357,372 10.9 Except as otherwise expressly provided herein, the information in this report does not reflect the consummation of the Business Combination, which occurred subsequent to the period covered hereunder. Initial Public Offering The registration statement for the Initial Public Offering (the “IPO”) was declared effective on January 24, 2019 pursuant to Section 8(a) of the Securities Act of 1933, as amended. On January 31, 2019, the Company consummated the Initial Public Offering of 10,800,000 800,000 10.00 108,000,000 Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 395,000 10.00 3,950,000 Transaction costs amounted to $ 3,204,451 2,700,000 504,451 Following the closing of the Initial Public Offering on January 31, 2019, an amount of $ 108,000,000 10.00 Initial Business Combination Pursuant to the Nasdaq Capital Markets listing rules, the Company’s Initial Business Combination had to be with a target business or businesses whose collective fair market value is at least equal to 80% of the balance in the Trust Account at the time of the execution of a definitive agreement for such Initial Business Combination, although this could have entailed simultaneous acquisitions of several target businesses. Failure to Consummate an Initial Business Combination The Company initially had until July 31, 2020 to complete an Initial Business Combination. On July 29, 2020, the Company held a special meeting pursuant to which the Company’s shareholders approved extending the date by which the Company had to complete an Initial Business Combination from July 31, 2020 to October 31, 2020 (or December 31, 2020 if the Company had executed a definitive agreement for an Initial Business Combination by October 31, 2020). In connection with the approval of the extension, shareholders elected to redeem an aggregate of 4,303,096 44,063,656 10.24 On October 28, 2020, the Company held a special meeting pursuant to which the Company’s shareholders approved extending the date by which the Company had to complete an Initial Business Combination from October 31, 2020 to January 31, 2021 (or April 30, 2021 if the Company had executed a definitive agreement for an Initial Business Combination by January 31, 2021) (such date or later date, as applicable, the “Extended Date”). In connection with the approval of the extension, shareholders elected to redeem an aggregate of 5,174,508 52,996,135 10.24 On January 27, 2021, the Company held a special meeting pursuant to which the Company’s shareholders approved extending the date by which the Company had to complete an Initial Business Combination from January 31, 2021 to April 30, 2021 (or July 31, 2021 if the Company has executed a definitive agreement for an Initial Business Combination by April 30, 2021) (such date or later date, as applicable, the “Extended Date”). In connection with the approval of the extension, shareholders elected to redeem an aggregate of 300 3,073 10.24 4,417,096 The Company completed an Initial Business Combination on July 20, 2021, which was the Business Combination with Stryve. Liquidity and Going Concern As of June 30, 2021, the Company had $ 59,163 13,543,086 322,199 Until the consummation of the Business Combination, the Company used the funds not held in the Trust Account for identifying and evaluating target businesses, performing due diligence on prospective target businesses, traveling to and from the offices, plants or similar location of prospective target businesses or their representatives or owners, reviewing corporate documents and material agreements of prospective target businesses and structuring, negotiating and completing an Initial Business Combination, which was the Business Combination with Stryve. As of June 30, 2021, the Company had working capital deficit of $ 2,079,174 Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or results of its operations, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 - Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC on February 18, 2021, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2020 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Use of Estimates The preparation of condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. Marketable Securities Held in Trust Account At June 30, 2021, the assets held in the Trust Account were substantially held in money market fund (Select Treasury Institutional Funds), which primarily invest in short term U.S. Treasury securities. The Company accounts for its securities held in the trust account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses, if any, recognized through the statement of operations. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities rather than equity on a SPAC’s balance sheet. Historically, the Company’s Private Warrants and Public Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the warrants, based on the Company’s application of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”). Some of the views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. After discussion and evaluation, including with the Company’s accounting advisor and the Company’s audit committee, and taking into consideration the SEC Staff Statement, management has concluded that the Company’s Private Warrants should be presented as liabilities with subsequent fair value remeasurement. Accordingly, the Company classifies the Private Warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the warrants initially was estimated using a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology. Net Income (Loss) per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at June 30, 2021 and December 31, 2020, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and the Private Placement to purchase 11,195,000 1,119,500 Reconciliation of Net Income (Loss) per Ordinary Share The Company’s net income (loss) is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per ordinary share is calculated as follows: Schedule of Basic and Diluted Loss Per Ordinary Share 2021 2020 2021 2020 Three Months Ended Six Months Ended June 30 2021 2020 2021 2020 Ordinary Shares subject to possible redemption Numerator: Earnings allocable to ordinary shares subject to possible redemption Interest income attributable to redeemable ordinary shares $ 260 $ 50,465 $ 506 $ 504,105 Net Income allocable to ordinary shares subject to possible redemption $ 260 $ 50,465 $ 506 $ 504,105 Denominator: Weighted Average ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding 1,322,096 10,332,435 1,046,175 10,338,488 Basic and diluted net income per redeemable ordinary share $ 0.00 $ 0.00 $ 0.00 $ 0.05 Non-Redeemable Ordinary Shares Numerator: Net Loss minus Net Earnings Net Loss $ (790,127 ) $ (781,003 ) $ (2,262,534 ) $ (447,824) Net Income allocable to ordinary shares stock subject to possible redemption (260 ) (50,465 ) (506 ) (504,105 ) Non-Redeemable Net Loss $ (790,387 ) $ (831,468 ) $ (2,263,040 ) $ (951,929) Denominator: Weighted Average Non-Redeemable ordinary shares Basic and diluted weighted average shares outstanding 3,095,000 3,562,575 3,370,969 3,556,513 Basic and diluted net loss per Non-Redeemable ordinary share $ (0.26 ) $ (0.23 ) $ (0.67 ) $ (0.27 ) Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021 and December 31, 2020, there were no no The Company may be subject to potential examination by foreign taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company was previously considered an exempted Cayman Islands company and was not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision is zero for all periods presented. As part of the Business Combination completed on July 20, 2021, the Company was domiciled in Delaware. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which, at times may exceed the federal depository insurance coverage of $ 250,000 Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed financial statements, primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2021
Initial Public Offering
Initial Public Offering	Note 3 - Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 10,800,000 $10.00 800,000 $10.00 Each Unit consists of one ordinary share of the Company, one right (the “Public Right”) and one redeemable warrant (the “Public Warrant”). Each Public Right entitles the holder to receive one-tenth (1/10) of an ordinary share upon consummation of an Initial Business Combination. Each Public Warrant entitles the holder to purchase one ordinary share at an exercise price of $ 11.50

Private Units

Private Units	6 Months Ended
	Jun. 30, 2021
Private Units
Private Units	Note 4 - Private Units Simultaneously with the closing of the Initial Public Offering, certain of the Initial Shareholders, including the underwriters in the Initial Public Offering (and their respective designees), purchased an aggregate of 395,000 $10.00 $3,950,000 Each Private Unit consists of one ordinary share (“Private Share”), one right (the “Private Right”) and one redeemable warrant (each, a “Private Warrant”). The proceeds from the Private Units have been added to the proceeds from the Initial Public Offering held in the Trust Account. The Private Units are identical to the Units sold in the Initial Public Offering except that the Private Warrants are non-redeemable and exercisable on a cashless basis so long as they are held by the initial purchasers or their permitted transferees. Additionally, the purchasers of the Private Units agreed (A) to vote the Private Shares in favor of any proposed Business Combination, (B) not to propose, or vote in favor of, an amendment to the Company’s amended and restated memorandum and articles of association with respect to its pre-Business Combination activities prior to the consummation of such an Initial Business Combination unless the Company provides public shareholders with the opportunity to convert their Public Shares in connection with any such vote, (C) not to convert any Private Shares into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a proposed initial Business Combination or a vote to amend the provisions of the Company’s amended and restated memorandum and articles of association relating to shareholders’ rights or pre-Business Combination activity and (D) that the Private Shares shall not participate in any liquidating distribution from the Trust Account upon winding up if an Initial Business Combination is not consummated. The purchasers of the Private Units have also agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to permitted transferees) until the completion of an initial Business Combination.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 - Related Party Transactions As of June 30, 2021 directors and officers had reimbursable expenses of $ 47,741

Commitments

Commitments	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 6 – Commitments Business Combination Marketing Agreement The Company engaged the joint book-running managers in the Initial Public Offering as advisors in connection with an Initial Business Combination to assist the Company in holding meetings with its shareholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with an Initial Business Combination, assist the Company in obtaining shareholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company agreed to pay the joint book-running managers aggregate cash fees for such services upon the consummation of an Initial Business Combination in an amount equal to $ 3.24 1.62 Fee Arrangements Following the Initial Public Offering, the Company entered into a letter agreement with a member of the Company’s board of directors that provides for a success fee to be paid to such director upon consummation of an Initial Business Combination with a target business introduced to the Company by such director in an amount equal to 0.6 In addition, the Company entered into several letter agreements with unaffiliated third parties that provide for a success fee to be paid to each such third party upon consummation of an Initial Business Combination with a target business introduced to the Company by such third party in amounts ranging from 0.75 1.0 Related to the business combination with Stryve, the Company entered into engagement letters with Cowen and Craig-Hallum, to be financial advisors and placement agent to the transaction, with an aggregate success fee of 2% of the transaction value and 6% fee of gross proceeds raised as agents and a capital markets advisory fee. The total amount paid under these engagement letters in connection with the Business Combination with Styve was $ 5.46 Registration Rights Pursuant to a registration rights agreement entered into on January 28, 2019, the holders of the insider shares, as well as the holders of the Private Units (and underlying securities) and any securities issued in payment of working capital loans made to the Company, are entitled to registration rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities. Notwithstanding anything to the contrary, the underwriters (and their designees) may only make a demand registration (i) on one occasion and (ii) during the five-year period beginning on January 28, 2019. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a majority of the Private Units (and underlying securities) and securities issued in payment of working capital loans (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates an Initial Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of an Initial Business Combination. Notwithstanding anything to the contrary, the underwriters (and their designees) may participate in a “piggy-back” registration only during the seven-year period beginning January 28, 2019. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Extension On January 5, 2021, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with Listing Rule 5620(a) and 5810(c)(2)(G), due to the Company’s failure to hold an annual meeting of stockholders within twelve months of the end of the Company’s fiscal year end. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Company held their 2020 general annual meeting on January 27, 2021 and intends to submit a plan of compliance with Nasdaq. On February 2, 2021, the Company received a letter from Nasdaq indicating it had regained compliance. On January 27, 2021, the Company held a special meeting pursuant to which the Company’s shareholders approved extending the date by which the Company had to complete an Initial Business Combination from January 31, 2021 to April 30, 2021 (or July 31, 2021 if the Company has executed a definitive agreement for an Initial Business Combination by April 30, 2021) (such date or later date, as applicable, the “Extended Date”). In connection with the approval of the extension, shareholders elected to redeem an aggregate of 300 3,073 $10.24 4,417,096 Business Combination Agreement On January 28, 2021, the Company entered into the Business Combination Agreement, which closed on July 20, 2021. See Note 1 for additional information. Simultaneously with the execution of the Business Combination Agreement, the Company and Stryve entered into subscription agreements with investors for an aggregate of $ 42,500,000 10.00 10,600,000 8.00

Shareholders_ Equity

Shareholders’ Equity	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Shareholders’ Equity	Note 7 - Shareholders’ Equity Ordinary Shares The Company was previously authorized to issue 100,000,000 $0.0001 3,095,000 3,650,004 1,322,096 767,392 In connection with the organization of the Company, a total of 2,875,000 $25,000 375,000 20 800,000 200,000 175,000 2,700,000 The Initial Shareholders have agreed not to transfer, assign or sell any of the insider shares (except to certain permitted transferees) until (1) with respect to 50% of the insider shares, the earlier of one year after the date of the consummation of an Initial Business Combination and the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after an Initial Business Combination and (2) with respect to the remaining 50% of the insider shares, one year after the date of the consummation of an Initial Business Combination, or earlier, in either case, if, subsequent to an Initial Business Combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Rights Each holder of a right will receive one-tenth (1/10) of one ordinary share upon consummation of an Initial Business Combination, even if a holder of such right converted all ordinary shares held by it in connection with an Initial Business Combination. The Company completed an Initial Business Combination on July 20, 2021, which was the Business Combination with Stryve. Each holder of a right received one-tenth (1/10) of one ordinary share upon consummation of the Business Combination with Styvve, even if a holder of such right converted all ordinary shares held by it. No fractional shares were issued upon exchange of the rights. Warrants The Public Warrants became exercisable upon the completion of the Business Combination with Stryve. However, except as set forth below, no Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the Public Warrants is not effective within 90 days from the consummation of an Initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that such exemption is available. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The warrants will expire five years from the consummation of an Initial Business Combination. The Company may call the Public Warrants for redemption (excluding the Private Warrants), in whole and not in part, at a price of $ .01 ● at any time while the warrants are exercisable, ● upon not less than 30 days’ prior written notice of redemption to each warrant holder, ● if, and only if, the reported last sale price of the ordinary shares equals or exceeds $ 18.00 ● if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the ordinary shares issuable upon the exercise of the Private Warrants were transferable, assignable or salable until after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. In addition, if  (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its Initial Business Combination at an issue price or effective issue price of less than $8.50 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to Company affiliates, without taking into account any insider shares held by such affiliates prior to such issuance) (where “insider shares” refers to the 2,875,000 ordinary shares held by the Company’s Initial Shareholders prior to the Company’s Initial Public Offering), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of its initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $8.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional ordinary shares or equity-linked securities. Additionally, in no event will the Company be required to net cash settle the warrants.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8 - Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value Assets Measured on Recurring Basis Description Level June 30, 2021 December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 13,543,086 13,545,503 Liabilities: Warrant Liability - Private Warrants 3 869,000 Marketable securities held in Trust Account As of June 30, 2021 and December 31, 2020, investment in the Trust Account consisted of $13,543,086 $13,545,503 Private Warrants The Private Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Company’s consolidated balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statement of operations. The Private Warrants were valued using a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology, which is considered to be a Level 3 fair value measurement. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. At the time of the IPO, in January 31, 2019, the Private Warrants liability had a fair value $0.41 $161,950 The key inputs into the binomial lattice model incorporating the Cox-Ross-Rubenstein methodology for the Private Warrants were as follows at June 30, 2021: Schedule of Binomial Lattice Model for Private Warrants Input June 30, 2021 Risk-free interest rate 0.77 % Dividend yield 0.00 % Selected volatility 18.9 % Exercise price $ 11.50 Market Stock Price $ 10.31 On June 30, 2021, the Private Placement Warrants were determined to be $2.20 $869,000 The following table presents the changes in the fair value of warrant liabilities for the period: Schedule of Changes in Fair Value of Warrant Liabilities Private Fair value as of June 30, 2021 $ 869,000

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 9 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. As described in Note 1, the Company completed the Business Combination on July 20, 2021. In connection with the closing of the Business Combination, the Company paid $ 10.4 7.8 37.9

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC on February 18, 2021, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2020 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Use of Estimates	Use of Estimates The preparation of condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At June 30, 2021, the assets held in the Trust Account were substantially held in money market fund (Select Treasury Institutional Funds), which primarily invest in short term U.S. Treasury securities. The Company accounts for its securities held in the trust account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses, if any, recognized through the statement of operations.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets.
Warrant Liability	Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities rather than equity on a SPAC’s balance sheet. Historically, the Company’s Private Warrants and Public Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the warrants, based on the Company’s application of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”). Some of the views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. After discussion and evaluation, including with the Company’s accounting advisor and the Company’s audit committee, and taking into consideration the SEC Staff Statement, management has concluded that the Company’s Private Warrants should be presented as liabilities with subsequent fair value remeasurement. Accordingly, the Company classifies the Private Warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the warrants initially was estimated using a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at June 30, 2021 and December 31, 2020, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and the Private Placement to purchase 11,195,000 1,119,500
Reconciliation of Net Income (Loss) per Ordinary Share	Reconciliation of Net Income (Loss) per Ordinary Share The Company’s net income (loss) is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per ordinary share is calculated as follows: Schedule of Basic and Diluted Loss Per Ordinary Share 2021 2020 2021 2020 Three Months Ended Six Months Ended June 30 2021 2020 2021 2020 Ordinary Shares subject to possible redemption Numerator: Earnings allocable to ordinary shares subject to possible redemption Interest income attributable to redeemable ordinary shares $ 260 $ 50,465 $ 506 $ 504,105 Net Income allocable to ordinary shares subject to possible redemption $ 260 $ 50,465 $ 506 $ 504,105 Denominator: Weighted Average ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding 1,322,096 10,332,435 1,046,175 10,338,488 Basic and diluted net income per redeemable ordinary share $ 0.00 $ 0.00 $ 0.00 $ 0.05 Non-Redeemable Ordinary Shares Numerator: Net Loss minus Net Earnings Net Loss $ (790,127 ) $ (781,003 ) $ (2,262,534 ) $ (447,824) Net Income allocable to ordinary shares stock subject to possible redemption (260 ) (50,465 ) (506 ) (504,105 ) Non-Redeemable Net Loss $ (790,387 ) $ (831,468 ) $ (2,263,040 ) $ (951,929) Denominator: Weighted Average Non-Redeemable ordinary shares Basic and diluted weighted average shares outstanding 3,095,000 3,562,575 3,370,969 3,556,513 Basic and diluted net loss per Non-Redeemable ordinary share $ (0.26 ) $ (0.23 ) $ (0.67 ) $ (0.27 )
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021 and December 31, 2020, there were no no The Company may be subject to potential examination by foreign taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company was previously considered an exempted Cayman Islands company and was not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision is zero for all periods presented. As part of the Business Combination completed on July 20, 2021, the Company was domiciled in Delaware.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which, at times may exceed the federal depository insurance coverage of $ 250,000
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed financial statements, primarily due to their short-term nature.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Schedule of Basic and Diluted Loss Per Ordinary Share	The Company’s net income (loss) is adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per ordinary share is calculated as follows: Schedule of Basic and Diluted Loss Per Ordinary Share 2021 2020 2021 2020 Three Months Ended Six Months Ended June 30 2021 2020 2021 2020 Ordinary Shares subject to possible redemption Numerator: Earnings allocable to ordinary shares subject to possible redemption Interest income attributable to redeemable ordinary shares $ 260 $ 50,465 $ 506 $ 504,105 Net Income allocable to ordinary shares subject to possible redemption $ 260 $ 50,465 $ 506 $ 504,105 Denominator: Weighted Average ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding 1,322,096 10,332,435 1,046,175 10,338,488 Basic and diluted net income per redeemable ordinary share $ 0.00 $ 0.00 $ 0.00 $ 0.05 Non-Redeemable Ordinary Shares Numerator: Net Loss minus Net Earnings Net Loss $ (790,127 ) $ (781,003 ) $ (2,262,534 ) $ (447,824) Net Income allocable to ordinary shares stock subject to possible redemption (260 ) (50,465 ) (506 ) (504,105 ) Non-Redeemable Net Loss $ (790,387 ) $ (831,468 ) $ (2,263,040 ) $ (951,929) Denominator: Weighted Average Non-Redeemable ordinary shares Basic and diluted weighted average shares outstanding 3,095,000 3,562,575 3,370,969 3,556,513 Basic and diluted net loss per Non-Redeemable ordinary share $ (0.26 ) $ (0.23 ) $ (0.67 ) $ (0.27 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value Assets Measured on Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value Assets Measured on Recurring Basis Description Level June 30, 2021 December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 13,543,086 13,545,503 Liabilities: Warrant Liability - Private Warrants 3 869,000
Schedule of Binomial Lattice Model for Private Warrants	The key inputs into the binomial lattice model incorporating the Cox-Ross-Rubenstein methodology for the Private Warrants were as follows at June 30, 2021: Schedule of Binomial Lattice Model for Private Warrants Input June 30, 2021 Risk-free interest rate 0.77 % Dividend yield 0.00 % Selected volatility 18.9 % Exercise price $ 11.50 Market Stock Price $ 10.31
Schedule of Changes in Fair Value of Warrant Liabilities	The following table presents the changes in the fair value of warrant liabilities for the period: Schedule of Changes in Fair Value of Warrant Liabilities Private Fair value as of June 30, 2021 $ 869,000

Organization and Plan of Busi_2

Organization and Plan of Business Operations (Details Narrative) - USD ($)	Jul. 20, 2021	Jan. 27, 2021	Oct. 28, 2020	Jul. 29, 2020	Jan. 31, 2019	Jun. 30, 2021	Dec. 31, 2020	Jun. 28, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares, par value						$ 0.0001	$ 0.0001
Sale of Stock, Price Per Share						$ 18
Transaction costs							$ 3,204,451
Expense Related to Distribution or Servicing and Underwriting Fees							2,700,000
Offering costs							$ 504,451
Common Stock, Shares, Outstanding						3,095,000	3,650,004
Cash						$ 59,163	$ 198,192
Assets Held-in-trust, Noncurrent						13,543,086
Deposits Assets, Noncurrent						322,199
Working capital deficit						$ 2,079,174
Trust Account [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Redeemed or Called During Period, Shares		300
Stock Redeemed or Called During Period, Value		$ 3,073	$ 52,996,135	$ 44,063,656
Redemption share price		$ 10.24	$ 10.24	$ 10.24
Common Stock, Shares, Outstanding		4,417,096
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Redeemed or Called During Period, Shares		300	5,174,508	4,303,096
Trust Account [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business Acquisition, Description of Acquired Entity						Pursuant to the Nasdaq Capital Markets listing rules, the Company’s Initial Business Combination had to be with a target business or businesses whose collective fair market value is at least equal to 80% of the balance in the Trust Account at the time of the execution of a definitive agreement for such Initial Business Combination, although this could have entailed simultaneous acquisitions of several target businesses.
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues					10,800,000	10,800,000
Shares Issued, Price Per Share						$ 10
Proceeds from Issuance Initial Public Offering					$ 108,000,000
Over-Allotment Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues					800,000	800,000
Shares Issued, Price Per Share					$ 10	$ 10
Private Placement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares Issued, Price Per Share								$ 10
Sale of Stock, Number of Shares Issued in Transaction					395,000
Sale of Stock, Price Per Share					$ 10
Proceeds from Issuance of Private Placement					$ 3,950,000
Class A Common Stock [Member] | Subsequent Event [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares, par value	$ 0.0001
Business Combination Agreement [Member] | Subsequent Event [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash and cash equivalents	$ 37,900,000
Payment related to redemption of shares	7,800,000
Payment of expenses and other liabilities due	10,400,000
Business Combination Agreement [Member] | Subsequent Event [Member] | Bridge Notes [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payment of principal and accrued interest	$ 10,900,000
Business Combination Agreement [Member] | Non-Voting Class B Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues	11,502,355
Business Combination Agreement [Member] | Class A Common Stock [Member] | Subsequent Event [Member] | Private Placement Investors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues	4,250,000
Aggregate consideration	$ 42,500,000
Business Combination Agreement [Member] | Class A Common Stock [Member] | Subsequent Event [Member] | Bridge PIPE Investment [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues	1,357,372

Schedule of Basic and Diluted L

Schedule of Basic and Diluted Loss Per Ordinary Share (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Accounting Policies [Abstract]
Interest income attributable to redeemable ordinary shares	$ 260		$ 50,465		$ 506	$ 504,105
Net Income allocable to ordinary shares subject to possible redemption	$ 260		$ 50,465		$ 506	$ 504,105
Basic and diluted weighted average shares outstanding	1,322,096		10,332,435		1,046,175	10,338,488
Basic and diluted net income per redeemable ordinary share	$ 0		$ 0		$ 0	$ 0.05
Net Loss	$ (790,127)	$ (1,472,407)	$ (781,003)	$ 333,179	$ (2,262,534)	$ (447,824)
Net Income allocable to ordinary shares stock subject to possible redemption	(260)		(50,465)		(506)	(504,105)
Non-Redeemable Net Loss	$ (790,387)		$ (831,468)		$ (2,263,040)	$ (951,929)
Basic and diluted weighted average shares outstanding	3,095,000		3,562,575		3,370,969	3,556,513
Basic and diluted net loss per Non-Redeemable ordinary share	$ (0.26)		$ (0.23)		$ (0.67)	$ (0.27)

Significant Accounting Polici_4

Significant Accounting Policies (Details Narrative) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Unrecognized tax benefits	$ 0	$ 0
Income tax accrued for interest and penalties	0	$ 0
Cash, FDIC insured amount	$ 250,000
IPO And Private Placement [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of warrant to purchase shares ordinary shares	1,119,500
Warrant [Member] | IPO And Private Placement [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of warrant to purchase shares ordinary shares	11,195,000

Initial Public Offering (Detail

Initial Public Offering (Details Narrative) - $ / shares	Jan. 31, 2019	Jun. 30, 2021
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price		$ 11.50
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of units issued	10,800,000	10,800,000
Shares issued price per share		$ 10
Initial public offering, description		Each Unit consists of one ordinary share of the Company, one right (the “Public Right”) and one redeemable warrant (the “Public Warrant”). Each Public Right entitles the holder to receive one-tenth (1/10) of an ordinary share upon consummation of an Initial Business Combination. Each Public Warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share (see Note 1 and Note 7).
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of units issued	800,000	800,000
Shares issued price per share	$ 10	$ 10

Private Units (Details Narrativ

Private Units (Details Narrative)	6 Months Ended
	Jun. 30, 2021USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Sale of unit price per share	$ 18
Private Units [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock units | shares	395,000
Sale of unit price per share	$ 10
Proceeds from private units | $	$ 3,950,000
Private units issued, description	Each Private Unit consists of one ordinary share (“Private Share”), one right (the “Private Right”) and one redeemable warrant (each, a “Private Warrant”). The proceeds from the Private Units have been added to the proceeds from the Initial Public Offering held in the Trust Account.

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	6 Months Ended
	Jun. 30, 2021USD ($)
Director [Member]
Related Party Transaction [Line Items]
Repayments of Related Party Debt	$ 47,741

Commitments (Details Narrative)

Commitments (Details Narrative) - USD ($)	Jul. 31, 2021	Jan. 27, 2021	Oct. 28, 2020	Jul. 29, 2020	Jun. 28, 2021	Jun. 30, 2021	Dec. 31, 2020
Loss Contingencies [Line Items]
Payments of fees in business combination						$ 5,460,000
Agent fees description						Related to the business combination with Stryve, the Company entered into engagement letters with Cowen and Craig-Hallum, to be financial advisors and placement agent to the transaction, with an aggregate success fee of 2% of the transaction value and 6% fee of gross proceeds raised as agents and a capital markets advisory fee. The total amount paid under these engagement letters in connection with the Business Combination with Styve was $5.46 million, including expenses
Common stock, shares, outstanding						3,095,000	3,650,004
Bridge Investors [Member]
Loss Contingencies [Line Items]
Shares issued, per share					$ 8
Unsecured promissory notes					$ 10,600,000
Private Placement [Member]
Loss Contingencies [Line Items]
Investee aggregate amount					$ 42,500,000
Shares issued, per share					$ 10
Trust Account [Member]
Loss Contingencies [Line Items]
Number of shares redeem aggregate ordinary shares		300
Number of shares redeem aggregate ordinary shares, value		$ 3,073	$ 52,996,135	$ 44,063,656
Share price		$ 10.24
Common stock, shares, outstanding		4,417,096
Business Combination Marketing Agreement [Member]
Loss Contingencies [Line Items]
Business combination contingent consideration liability						$ 3,240,000
Payments of fees in business combination	$ 1,620,000
Business Combination Marketing Agreement [Member] | Director [Member]
Loss Contingencies [Line Items]
Consideration paid percentage						0.60%
Letter Agreements [Member] | Unaffiliated Third Parties [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Consideration paid percentage						0.75%
Letter Agreements [Member] | Unaffiliated Third Parties [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Consideration paid percentage						1.00%

Shareholders_ Equity (Details N

Shareholders’ Equity (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common Stock, Shares, Outstanding	3,095,000	3,650,004
Common stock, shares, issued	3,095,000	3,650,004
Ordinary shares subject to redemption	1,322,096	767,392
Warrants redemption price per share	$ 0.01
Price per share	$ 18
Warrant Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Redemption of warrants, description	In addition, if  (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its Initial Business Combination at an issue price or effective issue price of less than $8.50 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to Company affiliates, without taking into account any insider shares held by such affiliates prior to such issuance) (where “insider shares” refers to the 2,875,000 ordinary shares held by the Company’s Initial Shareholders prior to the Company’s Initial Public Offering), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of its initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $8.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional ordinary shares or equity-linked securities. Additionally, in no event will the Company be required to net cash settle the warrants.
Initial Shareholders [Member]
Subsidiary, Sale of Stock [Line Items]
Number of ordinary shares sold	2,875,000
Purchase price of shares sold	$ 25,000
Number of shares subject to forfeiture	375,000
Percentage of issued and outstanding shares	20.00%
Initial Shareholders [Member] | Insider Shares [Member]
Subsidiary, Sale of Stock [Line Items]
Ordinary shares description	The Initial Shareholders have agreed not to transfer, assign or sell any of the insider shares (except to certain permitted transferees) until (1) with respect to 50% of the insider shares, the earlier of one year after the date of the consummation of an Initial Business Combination and the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after an Initial Business Combination and (2) with respect to the remaining 50% of the insider shares, one year after the date of the consummation of an Initial Business Combination, or earlier, in either case, if, subsequent to an Initial Business Combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Underwriters [Member] | Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Common Stock, Shares, Outstanding	2,700,000
Number of option shares purchased	800,000
Number of shares, no longer subject to forfeiture	200,000
Number of option shares forfeited	175,000
Holder [Member]
Subsidiary, Sale of Stock [Line Items]
Voting rights	Each holder of a right will receive one-tenth (1/10) of one ordinary share upon consummation of an Initial Business Combination, even if a holder of such right converted all ordinary shares held by it in connection with an Initial Business Combination.

Schedule of Fair Value Assets M

Schedule of Fair Value Assets Measured on Recurring Basis (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in Trust Account	$ 13,543,086	$ 13,545,503
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in Trust Account	13,543,086	$ 13,545,503
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability -Private Warrants	$ 869,000

Schedule of Binomial Lattice Mo

Schedule of Binomial Lattice Model for Private Warrants (Details) - Warrant [Member]	Jun. 30, 2021$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, per share	$ 11.50
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.0077
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.189
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, per share	$ 11.50
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, per share	$ 10.31

Schedule of Changes in Fair Val

Schedule of Changes in Fair Value of Warrant Liabilities (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair value of warrants	$ 98,750		$ 869,000

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative) - USD ($)	Jan. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Marketable securities held in Trust Account		$ 13,543,086		$ 13,543,086		$ 13,545,503
Fair value of warrants		$ 98,750		$ 869,000
Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair value of warrants price per shares	$ 0.41			$ 2.20
Fair value of warrants	$ 161,950			$ 869,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member] $ in Millions	Jul. 20, 2021USD ($)
Subsequent Event [Line Items]
Business combination contingent consideration liability	$ 10.4
Payments for redeeming stockholders	7.8
Proceeds from business acquisition	$ 37.9